Aesculin Possesses Potent Hypouricemic Action in Rodents but is Devoid of Xanthine Oxidase/Dehydrogenase Inhibitory Activity

Abstract

The natural product aesculin was demonstrated to possess potent hypouricemic effects in in vivo models of hyperuricemia in both mice and rats pretreated with oxonate. Aesculin, when administered intraperitoneally to the oxonate-induced hyperuricemic rodents, was able to elicit dose-dependent hypouricemic effects. At doses of 150 mg/kg of aesculin or above, the serum urate levels of the oxonate-pretreated mice were not different from normal mice. Such an effect in mice was observed as quick as 1.5 h after aesculin administration and was persistent for at least 5 h after aesculin administration. In rats, similar hypouricemic effects of intraperitoneally administered aesculin could also be demonstrated at doses of 100 mg/kg of aesculin or above, the serum urate levels of the oxonate-pretreated rats were not different from normal rats. Again, the effect persisted for at least 5 h after aesculin administration. In both rodents, however, oral administration at the same doses did not produce any observable hypouricemic effects. In addition, aesculin, when tested in vitro on rat and mouse liver homogenates, did not elicit any measurable inhibitory actions on the xanthine oxidase/xanthine dehydrogenase activities.

References

• 1 Star V L, Hochberg M. Prevention and management of gout.  Drug. 1993;  45 212-22
• 2 Wortmann R L. Management of hyperuricemia. In: McCarthy DJ, Koopman WJ, editors Arthritis and allied conditions. 12th ed. Philadelphia; Lea and Febiger 1993: 1807-18
• 3 Kelley W N. Antihyperuricemic drugs. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors Textbook of rheumatology. Philadelphia; W.B. Saunders 1991: 862-77
• 4 Hande K R, Noone R M, Stone W J. Severe allopurinol toxicity: description and guidelines for prevenyion in patients with renal insufficiency.  American Journal of Medicine. 1984;  76 47-52
• 5 Urban T, Maquarre E, Housset C, Chouaid C, Devin E, Lebeau B. Allopurinol hypersensitivity. A possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment.  Revue des Maladies Respiratoires. 1995;  12 314-6
• 6 Sumi S, Wada Y. Xanthine oxidase (xanthine dehydrogenase).  Nippon Rinsho - Japanese Journal of Clinical Medicine. 1996;  54 3226-9
• 7 Ivanovska N, Yossifova T, Vassileva E, Kostova I. Effect of some hydroxycoumarins on complement-mediated hemolysis in human serum.  Methods & Findings in Experimental & Clinical Pharmacology. 1994;  16 557-62
• 8 Stefanova Z, Neychev H, Ivanovska N, Kostova I. Effect of a total extract from Fraxinus ornus stem bark and aesculin on zymosan- and carrageenan-induced paw oedema in mice.  Journal of Ethnopharmacology. 1995;  46 101-6
• 9 Jiangsu College of New M edicine. The Dictionary of the Traditional Chinese Medicine. Shanghai Press of Science & Technology Shanghai; 1977: 1767-9
• 10 Chang W S, Chiang H C. Structure-activity relationship of coumarins in xanthine oxidase inhibition.  Anticancer Research. 1995;  15 (15B) 1969-73
• 11 Ferrand G, Dumas H, Decerprit J. Synthesis of new pteridines as hypouricemic agents.  Eur. J. Med. Chem.. 1992;  27 309-20
• 12 Hall I H, Scoville J P, Reynolds D J, Simlot R, Duncan P. Substituted cyclic imides as potencial anti-gout agents.  Life Sciences. 1990;  46 1923-7
• 13 Stavric B, Clayman S, Gradd R EA, Hebert D. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate.  Pharm Res. Comm.. 1975;  7 117-24
• 14 Carroll J J, Roberta Douglass H C, Babson A L. A simplified alkaline phosphotungstate assay for uric acid in serum.  Clinical Chemistry. 1971;  17 158-60